Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q4 2025 Earnings

5NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.93

-0.67

-0.41

-0.15

Details

Expected EPS

-0.39095

Actual EPS

-0.61

Surprise EPS

-0.22

Surprise Percent

+56.03%

Description

NewAmsterdam Pharma Company NV (NAMS) has reported earnings of -0.61 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.